Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning

D. Schmitt; D. Albers; F. Cremers

doi:10.1007/978-3-642-03474-9_72

Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning

D. Schmitt^*, D. Albers, F. Cremers

^*Corresponding author for this work

Clinic of Radiotherapy

University Hospital Hamburg-Eppendorf

Abstract

The TomoTherapy Hi-Art II treatment system and the Siemens Oncor offer the possibility to apply an MVCT for checking the patient position prior to treatment. TomoTherapy has a 3.5 MV fan beam MVCT and the Oncor a 6 MV cone beam MVCT. It was investigated whether these two MVCTs are appropriate for contouring and dose calculation in treatment planning. The contrast-to-noise- ratio and the dose to the patient were analyzed to answer the question if contouring based on these MVCT data is possible. The clinical usage of TomoTherapy MVCT in cases of two hip protheses and a prostate carcinoma serves as a reference to this estimation. It was found, that image quality was sufficient for contouring on the Oncor MVCT data if a much higher dose to the patient (about a factor of 12) compared to the TomoTherapy MVCT is accepted. To investigate whether these MVCTs are appropriate for dose calculation, it was checked whether the relation between CT value and electron density depends on the location within the patient. The relation of the Oncor MVCT highly depends on the location, which results in large deviations of the planned dose. Such dependence does not exist for the TomoTherapy MVCT. But, because of an inaccuracy in the reconstruction, an artifact is visible in the center of all TomoTherapy MVCT slices. The impact of this artifact on the dose calculation was found to be negligible. It can be concluded, that the Oncor MVCT is appropriate for contouring but currently inappropriate for dose calculation, while the TomoTherapy MVCT can be used for treatment planning.

Original language	English
Title of host publication	World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
Editors	Olaf Dössel, Wolfgang C. Schlegel
Number of pages	4
Volume	25
Publisher	Springer Vieweg, Berlin Heidelberg
Publication date	2009
Edition	1
Pages	252-255
ISBN (Print)	978-3-642-03472-5
ISBN (Electronic)	978-3-642-03474-9
DOIs	https://doi.org/10.1007/978-3-642-03474-9_72
Publication status	Published - 2009
Event	World Congress on Medical Physics and Biomedical Engineering: Diagnostic Imaging - Munich , Germany Duration: 07.09.2009 → 12.09.2009 Conference number: 81644

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-642-03474-9_72

Cite this

Schmitt, D., Albers, D., & Cremers, F. (2009). Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning. In O. Dössel, & W. C. Schlegel (Eds.), World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany (1 ed., Vol. 25, pp. 252-255). (IFMBE Proceedings; Vol. 25, No. 1). Springer Vieweg, Berlin Heidelberg. https://doi.org/10.1007/978-3-642-03474-9_72

@inproceedings{fcaccc669c824b558831e441eb9b46e0,

title = "Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning",

abstract = "The TomoTherapy Hi-Art II treatment system and the Siemens Oncor offer the possibility to apply an MVCT for checking the patient position prior to treatment. TomoTherapy has a 3.5 MV fan beam MVCT and the Oncor a 6 MV cone beam MVCT. It was investigated whether these two MVCTs are appropriate for contouring and dose calculation in treatment planning. The contrast-to-noise- ratio and the dose to the patient were analyzed to answer the question if contouring based on these MVCT data is possible. The clinical usage of TomoTherapy MVCT in cases of two hip protheses and a prostate carcinoma serves as a reference to this estimation. It was found, that image quality was sufficient for contouring on the Oncor MVCT data if a much higher dose to the patient (about a factor of 12) compared to the TomoTherapy MVCT is accepted. To investigate whether these MVCTs are appropriate for dose calculation, it was checked whether the relation between CT value and electron density depends on the location within the patient. The relation of the Oncor MVCT highly depends on the location, which results in large deviations of the planned dose. Such dependence does not exist for the TomoTherapy MVCT. But, because of an inaccuracy in the reconstruction, an artifact is visible in the center of all TomoTherapy MVCT slices. The impact of this artifact on the dose calculation was found to be negligible. It can be concluded, that the Oncor MVCT is appropriate for contouring but currently inappropriate for dose calculation, while the TomoTherapy MVCT can be used for treatment planning.",

author = "D. Schmitt and D. Albers and F. Cremers",

note = "Copyright: Copyright 2021 Elsevier B.V., All rights reserved.; World Congress on Medical Physics and Biomedical Engineering: Diagnostic Imaging ; Conference date: 07-09-2009 Through 12-09-2009",

year = "2009",

doi = "10.1007/978-3-642-03474-9_72",

language = "English",

isbn = "978-3-642-03472-5",

volume = "25",

series = "IFMBE Proceedings",

publisher = "Springer Vieweg, Berlin Heidelberg",

number = "1",

pages = "252--255",

editor = "D{\"o}ssel, {Olaf } and {C. Schlegel}, {Wolfgang }",

booktitle = "World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany",

edition = "1",

}

Schmitt, D, Albers, D & Cremers, F 2009, Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning. in O Dössel & W C. Schlegel (eds), World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany. 1 edn, vol. 25, IFMBE Proceedings, no. 1, vol. 25, Springer Vieweg, Berlin Heidelberg, pp. 252-255, World Congress on Medical Physics and Biomedical Engineering: Diagnostic Imaging, Munich , Bavaria, Germany, 07.09.09. https://doi.org/10.1007/978-3-642-03474-9_72

Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning. / Schmitt, D.; Albers, D.; Cremers, F.
World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany. ed. / Olaf Dössel; Wolfgang C. Schlegel. Vol. 25 1. ed. Springer Vieweg, Berlin Heidelberg, 2009. p. 252-255 (IFMBE Proceedings; Vol. 25, No. 1).

Research output: Chapters in Books/Reports/Conference Proceedings › Conference contribution › peer-review

TY - GEN

T1 - Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning

AU - Schmitt, D.

AU - Albers, D.

AU - Cremers, F.

N1 - Conference code: 81644

PY - 2009

Y1 - 2009

N2 - The TomoTherapy Hi-Art II treatment system and the Siemens Oncor offer the possibility to apply an MVCT for checking the patient position prior to treatment. TomoTherapy has a 3.5 MV fan beam MVCT and the Oncor a 6 MV cone beam MVCT. It was investigated whether these two MVCTs are appropriate for contouring and dose calculation in treatment planning. The contrast-to-noise- ratio and the dose to the patient were analyzed to answer the question if contouring based on these MVCT data is possible. The clinical usage of TomoTherapy MVCT in cases of two hip protheses and a prostate carcinoma serves as a reference to this estimation. It was found, that image quality was sufficient for contouring on the Oncor MVCT data if a much higher dose to the patient (about a factor of 12) compared to the TomoTherapy MVCT is accepted. To investigate whether these MVCTs are appropriate for dose calculation, it was checked whether the relation between CT value and electron density depends on the location within the patient. The relation of the Oncor MVCT highly depends on the location, which results in large deviations of the planned dose. Such dependence does not exist for the TomoTherapy MVCT. But, because of an inaccuracy in the reconstruction, an artifact is visible in the center of all TomoTherapy MVCT slices. The impact of this artifact on the dose calculation was found to be negligible. It can be concluded, that the Oncor MVCT is appropriate for contouring but currently inappropriate for dose calculation, while the TomoTherapy MVCT can be used for treatment planning.

AB - The TomoTherapy Hi-Art II treatment system and the Siemens Oncor offer the possibility to apply an MVCT for checking the patient position prior to treatment. TomoTherapy has a 3.5 MV fan beam MVCT and the Oncor a 6 MV cone beam MVCT. It was investigated whether these two MVCTs are appropriate for contouring and dose calculation in treatment planning. The contrast-to-noise- ratio and the dose to the patient were analyzed to answer the question if contouring based on these MVCT data is possible. The clinical usage of TomoTherapy MVCT in cases of two hip protheses and a prostate carcinoma serves as a reference to this estimation. It was found, that image quality was sufficient for contouring on the Oncor MVCT data if a much higher dose to the patient (about a factor of 12) compared to the TomoTherapy MVCT is accepted. To investigate whether these MVCTs are appropriate for dose calculation, it was checked whether the relation between CT value and electron density depends on the location within the patient. The relation of the Oncor MVCT highly depends on the location, which results in large deviations of the planned dose. Such dependence does not exist for the TomoTherapy MVCT. But, because of an inaccuracy in the reconstruction, an artifact is visible in the center of all TomoTherapy MVCT slices. The impact of this artifact on the dose calculation was found to be negligible. It can be concluded, that the Oncor MVCT is appropriate for contouring but currently inappropriate for dose calculation, while the TomoTherapy MVCT can be used for treatment planning.

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-77950444876&origin=inward&txGid=413d0bd2a20ab1bc1246f194ec78e229

U2 - 10.1007/978-3-642-03474-9_72

DO - 10.1007/978-3-642-03474-9_72

M3 - Conference contribution

SN - 978-3-642-03472-5

VL - 25

T3 - IFMBE Proceedings

SP - 252

EP - 255

BT - World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany

A2 - Dössel, Olaf

A2 - C. Schlegel, Wolfgang

PB - Springer Vieweg, Berlin Heidelberg

T2 - World Congress on Medical Physics and Biomedical Engineering: Diagnostic Imaging

Y2 - 7 September 2009 through 12 September 2009

ER -

Schmitt D, Albers D, Cremers F. Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning. In Dössel O, C. Schlegel W, editors, World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany. 1 ed. Vol. 25. Springer Vieweg, Berlin Heidelberg. 2009. p. 252-255. (IFMBE Proceedings; 1). doi: 10.1007/978-3-642-03474-9_72

Suitability of the MVCT of TomoTherapy and Siemens Oncor for Treatment Planning

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this